The 10-second takeaway
For the quarter ended March 31 (Q1), Life Technologies met expectations on revenues and beat slightly on earnings per share.
Compared to the prior-year quarter, revenue grew slightly. Non-GAAP earnings per share grew. GAAP earnings per share shrank.
Margins contracted across the board.
Life Technologies logged revenue of $962.5 million. The 17 analysts polled by S&P Capital IQ expected to see sales of $958.1 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.07. The 20 earnings estimates compiled by S&P Capital IQ predicted $1.05 per share. Non-GAAP EPS of $1.07 for Q1 were 8.1% higher than the prior-year quarter's $0.99 per share. GAAP EPS of $0.69 for Q1 were 4.2% lower than the prior-year quarter's $0.72 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 66.1%, 50 basis points worse than the prior-year quarter. Operating margin was 21.8%, 70 basis points worse than the prior-year quarter. Net margin was 12.6%, 150 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $968.9 million. On the bottom line, the average EPS estimate is $0.98.
Next year's average estimate for revenue is $3.88 billion. The average EPS estimate is $4.22.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 224 members out of 239 rating the stock outperform, and 15 members rating it underperform. Among 59 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 57 give Life Technologies a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Life Technologies is hold, with an average price target of $63.83.
Looking for alternatives to Life Technologies? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Life Technologies to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
The $1,000 Genome Marks the Start of a New Phase in Human Evolution
Unlocking the "human code" makes possible all manner of changes we might have never considered before. Are we ready for what that might mean?
Friday's Biggest Health-Care Winner: Illumina, Inc.
Illumina's new machine could be enormous for genome processing, and for investors.
Life Technologies Beats Analyst Estimates on EPS
Just the facts, Fool.